PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7623608-2	1995	Myo-inositol incorporation into HSF was dependent on an active transport system via Na(+)-K+ ATPase activity based on the results with Na+ deprivation and ouabain (5 mM).	Inositol	0-12	interleukin 6	Homo sapiens	32-35	
27658890-8	2016	Compared with placebo, myo-inositol intervention significantly reduced IL6 levels in BAL over 6 months (P = 0.03).	Inositol	23-35	interleukin 6	Homo sapiens	71-74	
17130674-5	2006	2-APB [(2-aminoethoxy)diphenylborane], an inositol 1,4,5-trisphosphate (IP(3))-receptor antagonist, inhibited UTP-induced IL-6 mRNA expression; and the action of A23187, a Ca(2+) ionophore, resembled the action of UTP.	Inositol	42-50	interleukin 6	Homo sapiens	122-126	
7623608-1	1995	The effects of elevated glucose and eicosapentaenoic acid (EPA, C20:5 omega 3) on myo-inositol uptake in human skin fibroblasts (HSF) were evaluated.	Inositol	82-94	interleukin 6	Homo sapiens	129-132	
32049375-7	2020	The MCI/MI- or MI- induced secretion of IL-1beta, TNF and IL-6 by PBMC was analysed by flow cytometry.	Inositol	8-10	interleukin 6	Homo sapiens	58-62	
32049375-7	2020	The MCI/MI- or MI- induced secretion of IL-1beta, TNF and IL-6 by PBMC was analysed by flow cytometry.	Inositol	15-17	interleukin 6	Homo sapiens	58-62	
32271462-7	2020	Myo-Inositol proved to reduce IL-6 levels in a number of conditions and to mitigate the inflammatory cascade, while being devoid of any significant side effects.	Inositol	0-12	interleukin 6	Homo sapiens	30-34	
33254564-0	2020	Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia?	Inositol	8-16	interleukin 6	Homo sapiens	60-64	
33493945-10	2021	Myo-inositol down-regulates the expression of IL-6 by phosphatidyl-inositol-3-kinase (PI3K) pathway.	Inositol	0-12	interleukin 6	Homo sapiens	46-50	
33254564-5	2020	In addition, myo-inositol has been found able to decrease the levels of IL-6 in several experimental settings, due to an effect on the inositol-requiring enzyme 1 (IRE1)-X-box-binding protein 1 (XBP1) and on the signal transducer and activator of transcription 3 (STAT3) pathways.	Inositol	13-25	interleukin 6	Homo sapiens	72-76	
33254564-6	2020	In this scenario, treatment with myo-inositol may be able to reduce IL-6 dependent inflammatory response and improve oxygenation in patients with severe ARDS by SARS-CoV-2.	Inositol	33-45	interleukin 6	Homo sapiens	68-72